Evidence on body weight, appetite, nutrition, activity, medications, and sustainable health outcomes without stigma or quick-fix claims.
In the Phase 3 TRANSCEND-T2D-2 trial, retatrutide vs Ozempic showed superior A1C reduction and double the weight loss. Here is what the science shows.
Retatrutide vs Ozempic: Head-to-Head A1C Trial Results Read More »
Discover how petrelintide and amylin agonists promote weight loss with far less nausea than GLP-1s. Here is what Phase 2 clinical trials reveal.
Petrelintide: New Weight Loss Drug Cuts Nausea vs GLP-1s Read More »
Does yo-yo dieting ruin your metabolism? Discover what 2026 clinical research in Nature and Lancet reveals about weight cycling and metabolic health.
Weight Cycling: Does Yo-Yo Dieting Ruin Your Metabolism? Read More »
Do statins cause weight gain? A look at what large studies and meta-analyses show about cholesterol-lowering statins and body weight.
Do Statins Cause Weight Gain? What Research Shows Read More »
Research links GLP-1 drugs like Ozempic and Wegovy to a higher risk of gastroparesis. Here’s what the evidence shows and warning signs to watch for.
GLP-1 Drugs and Gastroparesis: What Research Shows Read More »
Studies suggest statins may slightly raise weight, but heart benefits typically outweigh modest gains. Here’s what the science actually shows.
Do Statins Cause Weight Gain? What Research Shows Read More »
